TickerSpark Feed

life sciences

Everything tagged "life sciences" across research, earnings, and macro.

2 articles

Thermo Fisher Scientific (TMO): Quality Franchise, Price Debate

Thermo Fisher Scientific remains a top-tier life sciences platform with recurring revenue, strong cash flow, and multiple growth catalysts. The stock is a Buy, but the report argues the main question is valuation rather than business quality.

Apr 23, 2026·28 min read

Healthcare Diagnostics & Research Life Sciences

Research ReportDHR

Danaher (DHR): Recovery Momentum Meets Valuation Discipline

Danaher is emerging from a mixed-cycle recovery with improving bioprocessing orders, steady recurring revenue, and stronger EPS guidance. The stock looks attractive on a forward basis, but valuation still argues for buying on weakness.

Apr 22, 2026·28 min read

Healthcare Diagnostics & Research Healthcare

Want AI Research on Any Stock?

Generate a deep-dive report on any ticker. AI analyst, daily market intelligence, portfolio tools.

Get Full Access